R3R01ASFSGS201 Study Presentation and QampA

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=t1WYTactEsU

ASF recently invited River 3 Renal Corp. to provide information about R3R01-ASFSGS-201, a phase 2 clinical trial open to Alport patients that is testing an investigational medication called R3R01. This video features a presentation about the study from Guido Magni, MD, PhD, followed by a Q A session moderated by ASF's Patient Engagement Coordinator, Afton DeLucca. To learn more about this study, visit https://alportsyndrome.org/for-patien....

#############################

New on site